Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Preventive Effect of Trimetazidine on Contrast-Induced Acute Kidney Injury in Ckd Patients Based on Urinary Neutrophil Gelatinase-Associated Lipocalin (Ungal): A Randomized Clinical Trial Pubmed



Mirhosseini A1 ; Farahani B2 ; Gandomimohammadabadi A3 ; Keyvani H4 ; Biglariabhari M1 ; Davari A3 ; Vazirizadehmahabadi M3 ; Savaj S5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Firoozgar Hospital, Iran University of Medical Science, Tehran, Iran
  2. 2. Department of Cardiology, Firoozgar Hospital, Iran University of Medical Science Tehran, Iran
  3. 3. School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Virology Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Nephrology, Firoozgar Hospital, Iran University of Medical Science, Tehran, Iran

Source: Iranian Journal of Kidney Diseases Published:2019


Abstract

Introduction. Contrast-induced Acute Kidney Injury (CI-AKI) is a prevalent complication of chronic kidney disease (CKD) patients. The aim of this study was to evaluate the effects of periprocedural administration of trimetazidine as an anti-oxidant agent on the incidence of CI-AKI in CKD patients based on changes of Neutrophil Gelatinase-Associated Lipocalin (uNGAL) level, which has recently been introduced as an early predictor of CI-AKI. Methods. One hundred CKD patients with a mean GFR of 50 ± 7 cc/min who were candidate for coronary angiography assigned randomly to receive (50 patients, intervention group) or not receive (50 patients, control group) trimetazidine (70mg/d) for 72 hours. CI-AKI was defined as 0.5 mg or 25% increase in serum creatinine. We also checked uNGAL before and 12h after angiography. Results. Serum creatinine, showed a trend of less increment in the case group, although could not achieve a significant difference, there was a significant difference in urinary NGAL rise between two groups. CI-AKI was defined as 1.7 times increase in uNGAL level (12h after angiography to pre-procedurally uNGAL level ratio) according to the ROC curves. The incidence of CI-AKI according to urinary NGAL definition was 8% in the Trimetazidine group and 24% in the control group (P < .05). Conclusion. We concluded that Trimetazidine treatment before angiography may be effective in CI-AKI prevention. Moreover, it is shown that 1.7 times increase in urine NGAL after angiography is a valuable cut off point for clinicians to discriminate high risk patients for contrast nephropathy. © 2019, Iranian Society of Nephrology. All rights reserved.
Related Docs
Experts (# of related papers)